Marlon Braumann
Founder at Elevat3 Capital Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas Hanke | M | - |
Elevat3 Capital Ltd.
 Elevat3 Capital Ltd. Investment ManagersFinance Elevat3 Capital Ltd (Elevat3) is a venture capital firm, a subsidiary of Apeiron Investment Group Ltd. founded in 2020 by Christian Angermayer, Marlon Braumann and Thomas Hanke. The firm is headquartered in London, United Kingdom.
Ames Foundation
| 4 years |
| Thomas Hanke | M | - |
Amyriad Therapeutics, Inc.
 Amyriad Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Amyriad Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Los Angeles, CA. Amyriad Therapeutics, Inc. focuses on developing therapies for the relief of Alzheimer's disease symptoms. The company was founded by Christian Angermayer, Thomas Hanke, Anil K. Ratty, Marlon Braumann. The CEO is Sharon L. Rogers. | - |
| Christian Angermayer | M | - |
Amyriad Therapeutics, Inc.
Amyriad Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Amyriad Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Los Angeles, CA. Amyriad Therapeutics, Inc. focuses on developing therapies for the relief of Alzheimer's disease symptoms. The company was founded by Christian Angermayer, Thomas Hanke, Anil K. Ratty, Marlon Braumann. The CEO is Sharon L. Rogers. | - |
| Harald Mahrer | M | 51 |
Gropyus AG
 Gropyus AG HomebuildingConsumer Durables Gropyus AG is an Austrian company that operates as home builders. The company is based in Vienna, Austria. Markus Fuhrmann has been the CEO of the company since 2019. | - |
| Robin Haack | M | - |
Bullfinch Holding GmbH
 Bullfinch Holding GmbH Internet Software/ServicesTechnology Services Bullfinch Holding GmbH is a FinTech platform that pools, standardizes, finances and operates green and sustainable building and plant infrastructure projects. It serves Investors and CleanTechs. The company was founded by Robin Haack in 2019 and is headquartered in Munich, Germany. | 5 years |
| Hugo Mérida-Barba | M | - |
Bullfinch Holding GmbH
Bullfinch Holding GmbH Internet Software/ServicesTechnology Services Bullfinch Holding GmbH is a FinTech platform that pools, standardizes, finances and operates green and sustainable building and plant infrastructure projects. It serves Investors and CleanTechs. The company was founded by Robin Haack in 2019 and is headquartered in Munich, Germany. | - |
| Christian Angermayer | M | 45 |
Elevat3 Capital Ltd.
Elevat3 Capital Ltd. Investment ManagersFinance Elevat3 Capital Ltd (Elevat3) is a venture capital firm, a subsidiary of Apeiron Investment Group Ltd. founded in 2020 by Christian Angermayer, Marlon Braumann and Thomas Hanke. The firm is headquartered in London, United Kingdom. | 4 years |
| Arndt Neuhaus | M | 58 |
Bullfinch Holding GmbH
Bullfinch Holding GmbH Internet Software/ServicesTechnology Services Bullfinch Holding GmbH is a FinTech platform that pools, standardizes, finances and operates green and sustainable building and plant infrastructure projects. It serves Investors and CleanTechs. The company was founded by Robin Haack in 2019 and is headquartered in Munich, Germany. | - |
| Rebecca Kruse | F | - | 1 years | |
| Srinivas Rao | M | - |
Amyriad Therapeutics, Inc.
Amyriad Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Amyriad Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Los Angeles, CA. Amyriad Therapeutics, Inc. focuses on developing therapies for the relief of Alzheimer's disease symptoms. The company was founded by Christian Angermayer, Thomas Hanke, Anil K. Ratty, Marlon Braumann. The CEO is Sharon L. Rogers. | - |
| Ranga Rama Krishnan K. | M | - |
Amyriad Therapeutics, Inc.
Amyriad Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Amyriad Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Los Angeles, CA. Amyriad Therapeutics, Inc. focuses on developing therapies for the relief of Alzheimer's disease symptoms. The company was founded by Christian Angermayer, Thomas Hanke, Anil K. Ratty, Marlon Braumann. The CEO is Sharon L. Rogers. | - |
| Chaz De Naranjo | M | - |
Amyriad Therapeutics, Inc.
Amyriad Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Amyriad Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Los Angeles, CA. Amyriad Therapeutics, Inc. focuses on developing therapies for the relief of Alzheimer's disease symptoms. The company was founded by Christian Angermayer, Thomas Hanke, Anil K. Ratty, Marlon Braumann. The CEO is Sharon L. Rogers. | - |
| Sharon L. Rogers | F | - |
Amyriad Therapeutics, Inc.
Amyriad Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Amyriad Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Los Angeles, CA. Amyriad Therapeutics, Inc. focuses on developing therapies for the relief of Alzheimer's disease symptoms. The company was founded by Christian Angermayer, Thomas Hanke, Anil K. Ratty, Marlon Braumann. The CEO is Sharon L. Rogers. | - |
| Marcos Vaquer Caballería | M | 56 |
University Carlos III of Madrid
| 13 years |
| Christoph Rösler | M | - |
Ames Foundation
| 3 years |
| Wolfgang Hans Josef Hanrieder | M | 64 |
Bullfinch Holding GmbH
Bullfinch Holding GmbH Internet Software/ServicesTechnology Services Bullfinch Holding GmbH is a FinTech platform that pools, standardizes, finances and operates green and sustainable building and plant infrastructure projects. It serves Investors and CleanTechs. The company was founded by Robin Haack in 2019 and is headquartered in Munich, Germany. | - |
| Markus Fuhrmann | M | 44 |
Gropyus AG
Gropyus AG HomebuildingConsumer Durables Gropyus AG is an Austrian company that operates as home builders. The company is based in Vienna, Austria. Markus Fuhrmann has been the CEO of the company since 2019. | 5 years |
| Michael Menz | M | - |
Gropyus AG
Gropyus AG HomebuildingConsumer Durables Gropyus AG is an Austrian company that operates as home builders. The company is based in Vienna, Austria. Markus Fuhrmann has been the CEO of the company since 2019. | - |
| Abla Serghini | F | - |
Bullfinch Holding GmbH
Bullfinch Holding GmbH Internet Software/ServicesTechnology Services Bullfinch Holding GmbH is a FinTech platform that pools, standardizes, finances and operates green and sustainable building and plant infrastructure projects. It serves Investors and CleanTechs. The company was founded by Robin Haack in 2019 and is headquartered in Munich, Germany. | 4 years |
| Daniel Joachim Riedl | M | 54 |
Gropyus AG
Gropyus AG HomebuildingConsumer Durables Gropyus AG is an Austrian company that operates as home builders. The company is based in Vienna, Austria. Markus Fuhrmann has been the CEO of the company since 2019. | - |
| Richard Nilsson | M | 54 |
Gropyus AG
Gropyus AG HomebuildingConsumer Durables Gropyus AG is an Austrian company that operates as home builders. The company is based in Vienna, Austria. Markus Fuhrmann has been the CEO of the company since 2019. | - |
| Sonja Hammerschmid | M | - |
Gropyus AG
Gropyus AG HomebuildingConsumer Durables Gropyus AG is an Austrian company that operates as home builders. The company is based in Vienna, Austria. Markus Fuhrmann has been the CEO of the company since 2019. | 3 years |
| John G. Palfrey | M | - |
Ames Foundation
| - |
| Stefan Müller | M | 53 |
Bullfinch Holding GmbH
Bullfinch Holding GmbH Internet Software/ServicesTechnology Services Bullfinch Holding GmbH is a FinTech platform that pools, standardizes, finances and operates green and sustainable building and plant infrastructure projects. It serves Investors and CleanTechs. The company was founded by Robin Haack in 2019 and is headquartered in Munich, Germany. | - |
| Arthur Klausner | M | 64 |
Amyriad Therapeutics, Inc.
Amyriad Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Amyriad Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Los Angeles, CA. Amyriad Therapeutics, Inc. focuses on developing therapies for the relief of Alzheimer's disease symptoms. The company was founded by Christian Angermayer, Thomas Hanke, Anil K. Ratty, Marlon Braumann. The CEO is Sharon L. Rogers. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Evelyn Ocas Salazar | F | - |
University Carlos III of Madrid
| 5 years |
| Johannes Fontner | M | - | 1 years | |
| Marcos Alvarez Conde | M | - |
University Carlos III of Madrid
| 6 years |
| William Berke | M | - |
Robert H. Smith School of Business
| 4 years |
| Daniel López García | M | - |
University Carlos III of Madrid
| 4 years |
| Gili Naftalovich | F | - |
Robert H. Smith School of Business
| 4 years |
| Javier Castro | M | - |
University Carlos III of Madrid
| 4 years |
| Alessandra Farnum | F | - |
Robert H. Smith School of Business
| 4 years |
| Javier De Haro | M | - |
University Carlos III of Madrid
| 4 years |
| Santiago Mendez Cabezas | M | - |
University Carlos III of Madrid
| 4 years |
| Ryan Robert Kavel Turner | M | 45 |
Robert H. Smith School of Business
| 2 years |
| Alfonso Ortega Sanchez de Lerin | M | - |
University Carlos III of Madrid
| 5 years |
| Alvaro Gomez Martin | M | - |
University Carlos III of Madrid
| 6 years |
| Aaron Feierstein | M | - |
Robert H. Smith School of Business
| 3 years |
| Javier Fernández | M | - |
University Carlos III of Madrid
| 6 years |
| Alvaro Correas | M | - |
University Carlos III of Madrid
| 1 years |
| Enrique Andrés Abad | M | - |
University Carlos III of Madrid
| 4 years |
| Honorio Maura Suelves | M | - |
University Carlos III of Madrid
| 4 years |
| Pablo De Cos Igartua | M | - |
University Carlos III of Madrid
| 6 years |
| Edmundo Raúl Antonio Lizarzaburu Bolaños | M | 47 |
University Carlos III of Madrid
| 3 years |
| Jesús Pérez-Olleros Escandell | M | - |
University Carlos III of Madrid
| 4 years |
| Jorge Fernandez Quesada | M | - |
University Carlos III of Madrid
| 4 years |
| Laura Mallo López | F | - |
University Carlos III of Madrid
| 4 years |
| Jeff Wright | M | - |
Robert H. Smith School of Business
| 3 years |
| Gaspar de Osma | M | - |
University Carlos III of Madrid
| 4 years |
| Farhan Syed Mustafa | M | - |
Robert H. Smith School of Business
| 1 years |
| Martinas Terskin | M | - |
Robert H. Smith School of Business
| 4 years |
| Lourdes Álvarez de Toledo Valdés | F | - |
University Carlos III of Madrid
| 6 years |
| Luis M. Rosero | M | - |
Robert H. Smith School of Business
| 2 years |
| Herbert Eppich | M | - |
Robert H. Smith School of Business
| 4 years |
| Antonio Fernandez Elias | M | - |
University Carlos III of Madrid
| 6 years |
| Marco Pitrelli | M | - |
University Carlos III of Madrid
| 4 years |
| Jonatan Vega | M | - |
University Carlos III of Madrid
| 6 years |
| Daniela Tsoneva | F | - |
University Carlos III of Madrid
| 1 years |
| Janna Skinner | F | - |
Robert H. Smith School of Business
| 4 years |
| Li Shun Wu | M | 49 |
Robert H. Smith School of Business
| 2 years |
| Colin Mooney | M | - |
Robert H. Smith School of Business
| 4 years |
| Macarena González-Vigil Recoder | F | - |
University Carlos III of Madrid
| 4 years |
| Shandy Guharoy | M | - |
Robert H. Smith School of Business
| 1 years |
| Luke Wooten | M | - |
Robert H. Smith School of Business
| 4 years |
| Jason Fernandez | M | - |
Robert H. Smith School of Business
| 4 years |
| Maria Velasco Aguirre | F | - |
University Carlos III of Madrid
| 4 years |
| Alex Blum | M | - |
Robert H. Smith School of Business
| 4 years |
| Cody West | M | - |
Robert H. Smith School of Business
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Spain | 26 | 37.68% |
| United States | 25 | 36.23% |
| Germany | 9 | 13.04% |
| Austria | 6 | 8.70% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Marlon Braumann
- Personal Network
